Analyzing the Future of Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the ribose-nucleic acid (rna)-based therapeutics market grown over the years?
The market size for ribose-nucleic acid (RNA)-based therapeutics has seen significant growth in the past years. It is projected to rise from $15.79 billion in 2024 to $17.26 billion in 2025, recording a compound annual growth rate (CAGR) of 9.3%. The previous growth can be credited to the increase in investments and funding, the breakthrough of RNA interference (RNAi), clinical accomplishments of antisense oligonucleotides (ASOs), regulatory backing and structures, along with collaborations and partnerships.
What Is the forecasted market size and growth rate for the ribose-nucleic acid (rna)-based therapeutics market?
The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $24.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth.
Get your ribose-nucleic acid (rna)-based therapeutics market report here!
What are the major factors driving growth in the ribose-nucleic acid (rna)-based therapeutics market?
The escalating incidence of cancer is set to drive the expansion of the ribose-nucleic acid (RNA)-based therapeutics market. Considered a life-threatening condition, cancer is characterized by abnormal and uncontrolled growth of cells. Factors contributing to the prevalence of cancer include an aging demographic, lifestyle shifts, increased exposure to hazards, and improved methods of detection. RNA-based therapeutics are an emerging solution for cancer treatment, directly addressing its genetic and molecular basis. As per data from the Australian Institute of Health and Welfare in August 2023, approximately 151,000 people were confirmed with a cancer diagnosis (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021 in Australia. This number is projected to hit 185,000 by 2030. This rising occurrence of cancer is consequently fueling the growth of the ribose-nucleic acid (RNA)-based therapeutics market.
What key areas define the segmentation of the global ribose-nucleic acid (rna)-based therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
Who are the key players steering the development of the ribose-nucleic acid (rna)-based therapeutics market?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
What are the key trends shaping the future of the ribose-nucleic acid (rna)-based therapeutics market?
Key players in the market of ribose nucleic acid (RNA)-based therapeutics are concentrating their efforts in creating innovative medication solutions, such as mRNA (messenger RNA) -based booster vaccines. These efforts are intended to boost the efficiency of immunizations, tackle new viral strains, and enhance the longevity of the immunity provoked by vaccines. mRNA-based booster vaccines work by using messenger RNA to instruct the body’s cells to produce a protein that strengthens the immune defense against a specific infectious agent. For example, in June 2023, Gennova Biopharmaceuticals Ltd., a drug manufacturing company based in India, introduced GEMCOVAC-OM, the country’s first mRNA booster vaccine designed to specifically counter the Omicron variant of COVID-19. This booster is crucial given the reduced effectiveness of original vaccines on Omicron. Through the utilization of mRNA technology, GEMCOVAC-OM heightens the immune response and provides increased protection against the mutating virus.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
What regions are dominating the ribose-nucleic acid (rna)-based therapeutics market growth?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Nucleic Acid Based Gene Therapy Global Market Report 2024
Nucleic Acid Labeling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Space Militarization Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/space-militarization-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
